Literature DB >> 11511557

Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?

M F Dixon1, P M Neville, N P Mapstone, P Moayyedi, A T Axon.   

Abstract

BACKGROUND: There is increasing evidence that reflux of bile plays a part in the pathogenesis of Barrett's oesophagus. Bile injury to the gastric mucosa results in a "chemical" gastritis in which oedema and intestinal metaplasia are prominent. AIM: To determine if patients with Barrett's oesophagus have more bile related changes in antral mucosa than patients with uncomplicated gastro-oesophageal reflux disease (GORD) or non-ulcer dyspepsia (NUD). PATIENTS AND METHODS: Patients were identified by a retrospective search of pathology records and those with a clinically confirmed diagnosis of either Barrett's oesophagus or reflux oesophagitis who had oesophageal and gastric biopsies taken at the same endoscopy and had no evidence of Helicobacter pylori infection entered the study. Control biopsies were taken from H pylori negative NUD patients. Antral biopsies were examined "blind" to clinical group and graded for a series of histological features from which the "reflux gastritis score" (RGS) and "bile reflux index" (BRI) could be calculated. The reproducibility of these histological scores was tested by a second pathologist.
RESULTS: There were 100 patients with Barrett's, 61 with GORD, and 50 with NUD. The RGSs did not differ between groups. BRI values in the Barrett's group were significantly higher than those in GORD subjects (p=0.014) which in turn were higher than those in NUD patients (p=0.037). Similarly, the frequency of high BRI values (>14) was significantly greater in the Barrett's group (29/100; 29%) than in the GORD (9/61; 14.8%) or NUD (4/50; 8%) group. However, agreement on BRI values was "poor", indicating limited applicability of this approach.
CONCLUSION: Patients with Barrett's oesophagus have more evidence of bile related gastritis than subjects with uncomplicated GORD or NUD. The presence of bile in the refluxate could be a factor in both the development of "specialised" intestinal metaplasia and malignancy in the oesophagus.

Entities:  

Mesh:

Year:  2001        PMID: 11511557      PMCID: PMC1728451          DOI: 10.1136/gut.49.3.359

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

1.  Proton pump inhibitors for Barrett's oesophagus.

Authors:  G Triadafilopoulos
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 2.  Stem cells in epithelial tissues.

Authors:  J M Slack
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

3.  Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.

Authors:  J Theisen; D Nehra; D Citron; J Johansson; J A Hagen; P F Crookes; S R DeMeester; C G Bremner; T R DeMeester; J H Peters
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

Review 4.  Bile in the oesophagus: clinical relevance and ambulatory detection.

Authors:  R E Marshall; A Anggiansah; W J Owen
Journal:  Br J Surg       Date:  1997-01       Impact factor: 6.939

5.  Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus.

Authors:  R E Marshall; A Anggiansah; D K Manifold; W A Owen; W J Owen
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

6.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

7.  Reflux gastritis in gastroesophageal reflux disease: A histopathological study.

Authors:  M M Haber; I Lopez
Journal:  Ann Diagn Pathol       Date:  1999-10       Impact factor: 2.090

8.  Patterns of gastritis in patients with gastro-oesophageal reflux disease.

Authors:  D J Bowrey; G W Clark; G T Williams
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

9.  Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis.

Authors:  M Voutilainen; M Färkkilä; M Juhola; J P Mecklin; P Sipponen
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

10.  Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.

Authors:  H J Stein; W K Kauer; H Feussner; J R Siewert
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

View more
  22 in total

1.  Effects of bile reflux and intragastric microflora changes on lesions of remnant gastric mucosa after gastric operation.

Authors:  Chao Zhang; Zhan-Kui Liu; Pei-Wu Yu
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

2.  Barrett's Esophagus, fundoplication, and cancer.

Authors:  David I Watson; George C Mayne; Damian J Hussey
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

3.  Motion sensing superpixels (MOSES) is a systematic computational framework to quantify and discover cellular motion phenotypes.

Authors:  Felix Y Zhou; Carlos Ruiz-Puig; Richard P Owen; Michael J White; Jens Rittscher; Xin Lu
Journal:  Elife       Date:  2019-02-26       Impact factor: 8.140

4.  Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.

Authors:  Olga Chemnitzer; Katharina Götzel; Luisa Maurer; Arne Dietrich; Uwe Eichfeld; Orestis Lyros; Boris Jansen-Winkeln; Albrecht Hoffmeister; Ines Gockel; René Thieme
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

5.  Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux.

Authors:  Takeshi Tatsuta; Ken-Ichi Mukaisho; Hiroyuki Sugihara; Koichi Miwa; Tohru Tani; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

6.  Bile Reflux Scintigraphy After Mini-Gastric Bypass.

Authors:  Tuure Saarinen; Jari Räsänen; Jarmo Salo; Antti Loimaala; Miia Pitkonen; Marja Leivonen; Anne Juuti
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

7.  Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katerina Dvorak; George S Watts; Lois Ramsey; Hana Holubec; Claire M Payne; Carol Bernstein; Gareth J Jenkins; Richard E Sampliner; Anil Prasad; Harinder S Garewal; Harris Bernstein
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

8.  Bile reflux gastritis and intestinal metaplasia at the cardia.

Authors:  M F Dixon; N P Mapstone; P M Neville; P Moayyedi; A T R Axon
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Gallstones increase the prevalence of Barrett's esophagus.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Keiko Asakura; Yoshimasa Saito; Kenro Hirata; Toru Takebayashi; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-11-12       Impact factor: 7.527

10.  Bile acids induce cdx2 expression through the farnesoid x receptor in gastric epithelial cells.

Authors:  Yingji Xu; Toshio Watanabe; Tetsuya Tanigawa; Hirohisa Machida; Hirotoshi Okazaki; Hirokazu Yamagami; Kenji Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.